<article title='Calreticulin'><paragraph><template><target>distinguish</target><arg>calretinin</arg></template><template><target>PBB</target><arg name="geneid">811</arg></template></paragraph><paragraph><bold>Calreticulin</bold><space/>also known as<space/><bold>calregulin</bold>,<space/><bold>CRP55</bold>,<space/><bold>CaBP3</bold>,<space/><bold>calsequestrin-like protein</bold>, and<space/><bold>endoplasmic reticulum resident protein 60</bold><space/>(ERp60) is a<space/><link><target>protein</target></link><space/>that in humans is encoded by the<space/><italics>CALR</italics><space/><link><target>gene</target></link>.<extension extension_name='ref' name="pmid2365822"><template><target>cite journal</target><arg name="vauthors"><space/>McCauliffe DP, Zappi E, Lieu TS, Michalak M, Sontheimer RD, Capra JD<space/></arg><arg name="title"><space/>A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule"<space/></arg><arg name="journal"><space/>The Journal of Clinical Investigation<space/></arg><arg name="volume"><space/>86<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>332–5<space/></arg><arg name="date"><space/>Jul 1990<space/></arg><arg name="pmid"><space/>2365822<space/></arg><arg name="pmc"><space/>296725<space/></arg><arg name="doi"><space/>10.1172/JCI114704<space/></arg></template></extension><extension extension_name='ref' name="entrez"><template><target>cite web</target><arg name="title"><space/>Entrez Gene: calreticulin</arg><arg name="url"><space/>http://www.ncbi.nlm.nih.gov/sites/entrez?Db</arg><arg name="accessdate"><space/></arg></template></extension></paragraph><paragraph>Calreticulin is a multifunctional<space/><link><target>protein</target></link><space/>that binds<space/><link><target>calcium</target><part>Ca<xhtml:sup>2+</xhtml:sup></part></link><space/><link><target>ion</target><trail>s</trail></link><space/>(a<space/><link><target>second messenger</target></link><space/>in<space/><link><target>signal transduction</target></link>), rendering it inactive. The Ca<xhtml:sup>2+</xhtml:sup><space/>is bound with low<space/><link><target>chemical affinity</target><part>affinity</part></link>, but high<space/><link><target>valence (chemistry)</target><part>capacity</part></link>, and can be released on a signal (see<space/><link><target>inositol triphosphate</target></link>). Calreticulin is located in storage compartments associated with the<space/><link><target>endoplasmic reticulum</target></link>.<extension extension_name='ref' name="entrez"></extension></paragraph><paragraph>The term &quot;Mobilferrin&quot;<extension extension_name='ref'><template><target>MeshName</target><arg>Mobilferrin</arg></template></extension><space/>is considered to be the same as calreticulin by some sources.<extension extension_name='ref'><template><target>cite journal</target><arg name="vauthors"><space/>Beutler E, West C, Gelbart T<space/></arg><arg name="title"><space/>HLA-H and associated proteins in patients with hemochromatosis<space/></arg><arg name="journal"><space/>Molecular Medicine (Cambridge, Mass.)<space/></arg><arg name="volume"><space/>3<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>397–402<space/></arg><arg name="date"><space/>Jun 1997<space/></arg><arg name="pmid"><space/>9234244<space/></arg><arg name="pmc"><space/>2230203<space/></arg><arg name="doi"><space/></arg></template></extension></paragraph><heading level='2'>Function</heading><paragraph>Calreticulin binds to misfolded proteins and prevents them from being exported from the<space/><link><target>endoplasmic reticulum</target></link><space/>to the<space/><link><target>Golgi apparatus</target></link>.</paragraph><paragraph>A similar quality-control<space/><link><target>chaperone (protein)</target><part>molecular chaperone</part></link>,<space/><link><target>calnexin</target></link>, performs the same service for soluble proteins as does calreticulin. Both proteins, calnexin and calreticulin, have the function of binding to<space/><link><target>oligosaccharide</target><trail>s</trail></link><space/>containing terminal glucose residues, thereby targeting them for degradation. In normal cellular function, trimming of glucose residues off the core oligosaccharide added during N-linked<space/><link><target>glycosylation</target></link><space/>is a part of protein processing. If &quot;overseer&quot; enzymes note that residues are misfolded, proteins within the<space/><link><target>rough endoplasmic reticulum</target><part>rER</part></link><space/>will re-add glucose residues so that other calreticulin/calnexin can bind to these proteins and prevent them from proceeding to the Golgi. This leads these aberrantly folded proteins down a path whereby they are targeted for degradation.</paragraph><paragraph>Studies on transgenic mice reveal that calreticulin is a cardiac embryonic gene that is essential during development.<extension extension_name='ref' name="pmid12445456"><template><target>cite journal</target><arg name="vauthors"><space/>Michalak M, Lynch J, Groenendyk J, Guo L, Robert Parker JM, Opas M<space/></arg><arg name="title"><space/>Calreticulin in cardiac development and pathology<space/></arg><arg name="journal"><space/>Biochimica Et Biophysica Acta<space/></arg><arg name="volume"><space/>1600<space/></arg><arg name="issue"><space/>1-2<space/></arg><arg name="pages"><space/>32–7<space/></arg><arg name="date"><space/>Nov 2002<space/></arg><arg name="pmid"><space/>12445456<space/></arg><arg name="doi"><space/>10.1016/S1570-9639(02)00441-7<space/></arg></template></extension></paragraph><paragraph>Calreticulin and calnexin are also integral proteins in the production of<space/><link><target>MHC class I</target></link><space/>Proteins. As newly synthesized MHC class I -chains enter the endoplasmic reticulum, calnexin binds on to them retaining them in a partly folded state.<extension extension_name='ref'><template><target>cite book</target><arg name="author"><space/>Murphy K<space/></arg><arg name="title">Janeway's Immunobiology<space/></arg><arg name="date"><space/>2011<space/></arg><arg name="publisher"><space/>Taylor & Francis<space/></arg><arg name="location"><space/>Oxford<space/></arg><arg name="isbn"><space/>978-0815342434<space/></arg><arg name="edition"><space/>8th</arg></template></extension><space/>After the 2-microglobulin binds to the peptide-loading complex (PLC), calreticulin (along with<space/><link><target>ERp57</target></link><space/>takes over the job of chaperoning the MHC class I protein while the<space/><link><target>tapasin</target></link><space/>links the complex to the<space/><link><target>transporter associated with antigen processing</target></link><space/>(TAP) complex. This association prepares the MHC class I for binding an antigen for presentation on the cell surface.</paragraph><heading level='3'>Transcription regulation</heading><paragraph>Calreticulin is also found in the nucleus, suggesting that it may have a role in transcription regulation. Calreticulin binds to the<space/><link><target>synthetic peptide</target></link><space/>KLGFFKR, which is almost identical to an amino acid sequence in the<space/><link><target>DNA-binding domain</target></link><space/>of the superfamily of<space/><link><target>nuclear receptor</target><trail>s</trail></link>. The<space/><link><target>N-terminus</target><part>amino terminus</part></link><space/>of calreticulin interacts with the DNA-binding domain of the<space/><link><target>glucocorticoid receptor</target></link><space/>and prevents the receptor from binding to its specific<space/><link><target>glucocorticoid response element</target></link>. Calreticulin can inhibit the binding of<space/><link><target>androgen receptor</target></link><space/>to its hormone-responsive DNA element and can inhibit androgen receptor and<space/><link><target>retinoic acid receptor</target></link><space/>transcriptional activities in vivo, as well as retinoic acid-induced neuronal differentiation. Thus, calreticulin can act as an important modulator of the regulation of gene transcription by nuclear hormone receptors.</paragraph><heading level='2'>Clinical significance</heading><paragraph>Calreticulin binds to<space/><link><target>antibody</target><part>antibodies</part></link><space/>in certain sera of<space/><link><target>Lupus erythematosus</target><part>systemic lupus</part></link><space/>and<space/><link><target>Sjgren's syndrome</target><part>Sjogren</part></link><space/>patients that contain<space/><link><target>Anti-SSA/Ro autoantibodies</target><part>anti-Ro/SSA antibodies</part></link>. Systemic lupus erythematosus is associated with increased autoantibody titers against calreticulin, but calreticulin is not a Ro/SS-A antigen. Earlier papers referred to calreticulin as an Ro/SS-A antigen, but this was later disproven. Increased autoantibody titer against human calreticulin is found in infants with complete congenital heart block of both the<space/><link><target>IgG</target></link><space/>and<space/><link><target>IgM</target></link><space/>classes.<extension extension_name='ref'><template><target>cite web</target><arg name="title"><space/>Entrez Gene: CALR calreticulin</arg><arg name="url"><space/>http://www.ncbi.nlm.nih.gov/sites/entrez?Db</arg><arg name="accessdate"><space/></arg></template></extension></paragraph><paragraph>In 2013, two groups detected calreticulin mutations in a majority of<space/><link><target>Janus kinase 2</target><part>JAK2</part></link>-negative/<link><target>thrombopoietin receptor</target><part>MPL</part></link>-negative patients with<space/><link><target>essential thrombocytosis</target></link><space/>and<space/><link><target>myelofibrosis</target><part>primary myelofibrosis</part></link>, which makes<space/><italics>CALR</italics><space/>mutations the second most common in<space/><link><target>myeloproliferative disease</target><part>myeloproliferative neoplasms</part></link>. All mutations (insertions or deletions) affected the last exon, generating a reading<space/><link><target>Frameshift mutation</target><part>frame shift</part></link><space/>of the resulting protein, that creates a novel terminal peptide and causes a loss of endoplasmic reticulum<space/><link><target>ER retention</target><part>KDEL retention signal</part></link>.<extension extension_name='ref' name="pmid24325359"><template><target>cite journal</target><arg name="vauthors"><space/>Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC, Avezov E, Li J, Kollmann K, Kent DG, Aziz A, Godfrey AL, Hinton J, Martincorena I, Van Loo P, Jones AV, Guglielmelli P, Tarpey P, Harding HP, Fitzpatrick JD, Goudie CT, Ortmann CA, Loughran SJ, Raine K, Jones DR, Butler AP, Teague JW, O'Meara S, McLaren S, Bianchi M, Silber Y, Dimitropoulou D, Bloxham D, Mudie L, Maddison M, Robinson B, Keohane C, Maclean C, Hill K, Orchard K, Tauro S, Du MQ, Greaves M, Bowen D, Huntly BJ, Harrison CN, Cross NC, Ron D, Vannucchi AM, Papaemmanuil E, Campbell PJ, Green AR<space/></arg><arg name="title"><space/>Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2<space/></arg><arg name="journal"><space/>The New England Journal of Medicine<space/></arg><arg name="volume"><space/>369<space/></arg><arg name="issue"><space/>25<space/></arg><arg name="pages"><space/>2391–405<space/></arg><arg name="date"><space/>Dec 2013<space/></arg><arg name="pmid"><space/>24325359<space/></arg><arg name="pmc"><space/>3966280<space/></arg><arg name="doi"><space/>10.1056/NEJMoa1312542<space/></arg></template></extension><extension extension_name='ref' name="pmid24325356"><template><target>cite journal</target><arg name="vauthors"><space/>Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, Them NC, Berg T, Gisslinger B, Pietra D, Chen D, Vladimer GI, Bagienski K, Milanesi C, Casetti IC, Sant'Antonio E, Ferretti V, Elena C, Schischlik F, Cleary C, Six M, Schalling M, Schönegger A, Bock C, Malcovati L, Pascutto C, Superti-Furga G, Cazzola M, Kralovics R<space/></arg><arg name="title"><space/>Somatic mutations of calreticulin in myeloproliferative neoplasms<space/></arg><arg name="journal"><space/>The New England Journal of Medicine<space/></arg><arg name="volume"><space/>369<space/></arg><arg name="issue"><space/>25<space/></arg><arg name="pages"><space/>2379–90<space/></arg><arg name="date"><space/>Dec 2013<space/></arg><arg name="pmid"><space/>24325356<space/></arg><arg name="doi"><space/>10.1056/NEJMoa1311347<space/></arg></template></extension></paragraph><heading level='2'>Role in cancer</heading><paragraph>Calreticulin (CRT) is expressed in many cancer cells and plays a role to promote<space/><link><target>macrophage</target><trail>s</trail></link><space/>to engulf hazardous cancerous cells. The reason why most of the cells are not destroyed is the presence of another molecule with signal<space/><link><target>CD47</target></link>, which blocks CRT. Hence antibodies that block CD47 might be useful as a cancer treatment. In mice models of<space/><link><target>myeloid leukemia</target></link><space/>and<space/><link><target>non-Hodgkins lymphoma</target></link>, anti-CD47 were effective in clearing cancer cells while normal cells were unaffected.<extension extension_name='ref' name="pmid21178137"><template><target>cite journal</target><arg name="vauthors"><space/>Chao MP, Jaiswal S, Weissman-Tsukamoto R, Alizadeh AA, Gentles AJ, Volkmer J, Weiskopf K, Willingham SB, Raveh T, Park CY, Majeti R, Weissman IL<space/></arg><arg name="title"><space/>Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47<space/></arg><arg name="journal"><space/>Science Translational Medicine<space/></arg><arg name="volume"><space/>2<space/></arg><arg name="issue"><space/>63<space/></arg><arg name="pages"><space/>63ra94<space/></arg><arg name="date"><space/>Dec 2010<space/></arg><arg name="pmid"><space/>21178137<space/></arg><arg name="pmc"><space/>4126904<space/></arg><arg name="doi"><space/>10.1126/scitranslmed.3001375<space/></arg><arg name="laysummary"><space/>http://med.stanford.edu/ism/2010/december/crt-signal.html<space/></arg><arg name="laysource"><space/>Stanford School of Medicine<space/></arg></template></extension></paragraph><heading level='2'>Interactions</heading><paragraph>Calreticulin has been shown to<space/><link><target>protein-protein interaction</target><part>interact</part></link><space/>with<space/><link><target>Perforin</target></link><extension extension_name='ref' name="pmid9671507"><template><target>cite journal</target><arg name="vauthors"><space/>Andrin C, Pinkoski MJ, Burns K, Atkinson EA, Krahenbuhl O, Hudig D, Fraser SA, Winkler U, Tschopp J, Opas M, Bleackley RC, Michalak M<space/></arg><arg name="title"><space/>Interaction between a Ca2+-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules<space/></arg><arg name="journal"><space/>Biochemistry<space/></arg><arg name="volume"><space/>37<space/></arg><arg name="issue"><space/>29<space/></arg><arg name="pages"><space/>10386–94<space/></arg><arg name="date"><space/>Jul 1998<space/></arg><arg name="pmid"><space/>9671507<space/></arg><arg name="doi"><space/>10.1021/bi980595z<space/></arg></template></extension><space/>and<space/><link><target>NK2 homeobox 1</target></link>.<extension extension_name='ref' name="pmid9988700"><template><target>cite journal</target><arg name="vauthors"><space/>Perrone L, Tell G, Di Lauro R<space/></arg><arg name="title"><space/>Calreticulin enhances the transcriptional activity of thyroid transcription factor-1 by binding to its homeodomain<space/></arg><arg name="journal"><space/>The Journal of Biological Chemistry<space/></arg><arg name="volume"><space/>274<space/></arg><arg name="issue"><space/>8<space/></arg><arg name="pages"><space/>4640–5<space/></arg><arg name="date"><space/>Feb 1999<space/></arg><arg name="pmid"><space/>9988700<space/></arg><arg name="doi"><space/>10.1074/jbc.274.8.4640<space/></arg></template></extension><template><target>Clear</target></template></paragraph><heading level='2'>References</heading><paragraph><template><target>Reflist</target><arg>33em</arg></template></paragraph><heading level='2'>Further reading</heading><paragraph><template><target>refbegin</target><arg>33em</arg></template></paragraph><list type='bullet'><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Del Bem LE<space/></arg><arg name="title"><space/>The evolutionary history of calreticulin and calnexin genes in green plants<space/></arg><arg name="journal"><space/>Genetica<space/></arg><arg name="volume"><space/>139<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>225–9<space/></arg><arg name="date"><space/>Feb 2011<space/></arg><arg name="pmid"><space/>21222018<space/></arg><arg name="doi"><space/>10.1007/s10709-010-9544-y<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Coppolino MG, Dedhar S<space/></arg><arg name="title"><space/>Calreticulin<space/></arg><arg name="journal"><space/>The International Journal of Biochemistry & Cell Biology<space/></arg><arg name="volume"><space/>30<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>553–8<space/></arg><arg name="date"><space/>May 1998<space/></arg><arg name="pmid"><space/>9693955<space/></arg><arg name="doi"><space/>10.1016/S1357-2725(97)00153-2<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Brucato A, Grava C, Bortolati M, Ikeda K, Milanesi O, Cimaz R, Ramoni V, Vignati G, Martinelli S, Sadou Y, Borghi A, Tincani A, Chan EK, Ruffatti A<space/></arg><arg name="title"><space/>Congenital heart block not associated with anti-Ro/La antibodies: comparison with anti-Ro/La-positive cases<space/></arg><arg name="journal"><space/>The Journal of Rheumatology<space/></arg><arg name="volume"><space/>36<space/></arg><arg name="issue"><space/>8<space/></arg><arg name="pages"><space/>1744–8<space/></arg><arg name="date"><space/>Aug 2009<space/></arg><arg name="pmid"><space/>19567621<space/></arg><arg name="pmc"><space/>2798588<space/></arg><arg name="doi"><space/>10.3899/jrheum.080737<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Peng RQ, Chen YB, Ding Y, Zhang R, Zhang X, Yu XJ, Zhou ZW, Zeng YX, Zhang XS<space/></arg><arg name="title"><space/>Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer<space/></arg><arg name="journal"><space/>World Journal of Gastroenterology : WJG<space/></arg><arg name="volume"><space/>16<space/></arg><arg name="issue"><space/>19<space/></arg><arg name="pages"><space/>2428–34<space/></arg><arg name="date"><space/>May 2010<space/></arg><arg name="pmid"><space/>20480531<space/></arg><arg name="pmc"><space/>2874150<space/></arg><arg name="doi"><space/>10.3748/wjg.v16.i19.2428<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Tarr JM, Young PJ, Morse R, Shaw DJ, Haigh R, Petrov PG, Johnson SJ, Winyard PG, Eggleton P<space/></arg><arg name="title"><space/>A mechanism of release of calreticulin from cells during apoptosis<space/></arg><arg name="journal"><space/>Journal of Molecular Biology<space/></arg><arg name="volume"><space/>401<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>799–812<space/></arg><arg name="date"><space/>Sep 2010<space/></arg><arg name="pmid"><space/>20624402<space/></arg><arg name="doi"><space/>10.1016/j.jmb.2010.06.064<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Abd Alla J, Reeck K, Langer A, Streichert T, Quitterer U<space/></arg><arg name="title"><space/>Calreticulin enhances B2 bradykinin receptor maturation and heterodimerization<space/></arg><arg name="journal"><space/>Biochemical and Biophysical Research Communications<space/></arg><arg name="volume"><space/>387<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>186–90<space/></arg><arg name="date"><space/>Sep 2009<space/></arg><arg name="pmid"><space/>19580784<space/></arg><arg name="doi"><space/>10.1016/j.bbrc.2009.07.011<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Caramelo JJ, Parodi AJ<space/></arg><arg name="title"><space/>Getting in and out from calnexin/calreticulin cycles<space/></arg><arg name="journal"><space/>The Journal of Biological Chemistry<space/></arg><arg name="volume"><space/>283<space/></arg><arg name="issue"><space/>16<space/></arg><arg name="pages"><space/>10221–5<space/></arg><arg name="date"><space/>Apr 2008<space/></arg><arg name="pmid"><space/>18303019<space/></arg><arg name="pmc"><space/>2447651<space/></arg><arg name="doi"><space/>10.1074/jbc.R700048200<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Du XL, Yang H, Liu SG, Luo ML, Hao JJ, Zhang Y, Lin DC, Xu X, Cai Y, Zhan QM, Wang MR<space/></arg><arg name="title"><space/>Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma<space/></arg><arg name="journal"><space/>Oncogene<space/></arg><arg name="volume"><space/>28<space/></arg><arg name="issue"><space/>42<space/></arg><arg name="pages"><space/>3714–22<space/></arg><arg name="date"><space/>Oct 2009<space/></arg><arg name="pmid"><space/>19684620<space/></arg><arg name="doi"><space/>10.1038/onc.2009.237<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Gelebart P, Opas M, Michalak M<space/></arg><arg name="title"><space/>Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum<space/></arg><arg name="journal"><space/>The International Journal of Biochemistry & Cell Biology<space/></arg><arg name="volume"><space/>37<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>260–6<space/></arg><arg name="date"><space/>Feb 2005<space/></arg><arg name="pmid"><space/>15474971<space/></arg><arg name="doi"><space/>10.1016/j.biocel.2004.02.030<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Qiu Y, Michalak M<space/></arg><arg name="title"><space/>Transcriptional control of the calreticulin gene in health and disease<space/></arg><arg name="journal"><space/>The International Journal of Biochemistry & Cell Biology<space/></arg><arg name="volume"><space/>41<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>531–8<space/></arg><arg name="date"><space/>Mar 2009<space/></arg><arg name="pmid"><space/>18765291<space/></arg><arg name="doi"><space/>10.1016/j.biocel.2008.06.020<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Zhu Y, Zhang W, Veerapen N, Besra G, Cresswell P<space/></arg><arg name="title"><space/>Calreticulin controls the rate of assembly of CD1d molecules in the endoplasmic reticulum<space/></arg><arg name="journal"><space/>The Journal of Biological Chemistry<space/></arg><arg name="volume"><space/>285<space/></arg><arg name="issue"><space/>49<space/></arg><arg name="pages"><space/>38283–92<space/></arg><arg name="date"><space/>Dec 2010<space/></arg><arg name="pmid"><space/>20861015<space/></arg><arg name="pmc"><space/>2992262<space/></arg><arg name="doi"><space/>10.1074/jbc.M110.170530<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Talmud PJ, Drenos F, Shah S, Shah T, Palmen J, Verzilli C, Gaunt TR, Pallas J, Lovering R, Li K, Casas JP, Sofat R, Kumari M, Rodriguez S, Johnson T, Newhouse SJ, Dominiczak A, Samani NJ, Caulfield M, Sever P, Stanton A, Shields DC, Padmanabhan S, Melander O, Hastie C, Delles C, Ebrahim S, Marmot MG, Smith GD, Lawlor DA, Munroe PB, Day IN, Kivimaki M, Whittaker J, Humphries SE, Hingorani AD<space/></arg><arg name="title"><space/>Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip<space/></arg><arg name="journal"><space/>American Journal of Human Genetics<space/></arg><arg name="volume"><space/>85<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>628–42<space/></arg><arg name="date"><space/>Nov 2009<space/></arg><arg name="pmid"><space/>19913121<space/></arg><arg name="pmc"><space/>2775832<space/></arg><arg name="doi"><space/>10.1016/j.ajhg.2009.10.014<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Taner SB, Pando MJ, Roberts A, Schellekens J, Marsh SG, Malmberg KJ, Parham P, Brodsky FM<space/></arg><arg name="title"><space/>Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention<space/></arg><arg name="journal"><space/>Journal of Immunology (Baltimore, Md. : 1950)<space/></arg><arg name="volume"><space/>186<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>62–72<space/></arg><arg name="date"><space/>Jan 2011<space/></arg><arg name="pmid"><space/>21115737<space/></arg><arg name="pmc"><space/>3129036<space/></arg><arg name="doi"><space/>10.4049/jimmunol.0903657<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Tarr JM, Winyard PG, Ryan B, Harries LW, Haigh R, Viner N, Eggleton P<space/></arg><arg name="title"><space/>Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells<space/></arg><arg name="journal"><space/>Arthritis and Rheumatism<space/></arg><arg name="volume"><space/>62<space/></arg><arg name="issue"><space/>10<space/></arg><arg name="pages"><space/>2919–29<space/></arg><arg name="date"><space/>Oct 2010<space/></arg><arg name="pmid"><space/>20533543<space/></arg><arg name="doi"><space/>10.1002/art.27602<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Kepp O, Gdoura A, Martins I, Panaretakis T, Schlemmer F, Tesniere A, Fimia GM, Ciccosanti F, Burgevin A, Piacentini M, Eggleton P, Young PJ, Zitvogel L, van Endert P, Kroemer G<space/></arg><arg name="title"><space/>Lysyl tRNA synthetase is required for the translocation of calreticulin to the cell surface in immunogenic death<space/></arg><arg name="journal"><space/>Cell Cycle (Georgetown, Tex.)<space/></arg><arg name="volume"><space/>9<space/></arg><arg name="issue"><space/>15<space/></arg><arg name="pages"><space/>3072–7<space/></arg><arg name="date"><space/>Aug 2010<space/></arg><arg name="pmid"><space/>20699648<space/></arg><arg name="doi"><space/>10.4161/cc.9.15.12459<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Sato H, Azuma Y, Higai K, Matsumoto K<space/></arg><arg name="title"><space/>Altered expression of glycoproteins on the cell surface of Jurkat cells during etoposide-induced apoptosis: shedding and intracellular translocation of glycoproteins<space/></arg><arg name="journal"><space/>Biochimica Et Biophysica Acta<space/></arg><arg name="volume"><space/>1790<space/></arg><arg name="issue"><space/>10<space/></arg><arg name="pages"><space/>1198–205<space/></arg><arg name="date"><space/>Oct 2009<space/></arg><arg name="pmid"><space/>19524015<space/></arg><arg name="doi"><space/>10.1016/j.bbagen.2009.05.019<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Hong C, Qiu X, Li Y, Huang Q, Zhong Z, Zhang Y, Liu X, Sun L, Lv P, Gao XM<space/></arg><arg name="title"><space/>Functional analysis of recombinant calreticulin fragment 39-272: implications for immunobiological activities of calreticulin in health and disease<space/></arg><arg name="journal"><space/>Journal of Immunology (Baltimore, Md. : 1950)<space/></arg><arg name="volume"><space/>185<space/></arg><arg name="issue"><space/>8<space/></arg><arg name="pages"><space/>4561–9<space/></arg><arg name="date"><space/>Oct 2010<space/></arg><arg name="pmid"><space/>20855873<space/></arg><arg name="doi"><space/>10.4049/jimmunol.1000536<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Alur M, Nguyen MM, Eggener SE, Jiang F, Dadras SS, Stern J, Kimm S, Roehl K, Kozlowski J, Pins M, Michalak M, Dhir R, Wang Z<space/></arg><arg name="title"><space/>Suppressive roles of calreticulin in prostate cancer growth and metastasis<space/></arg><arg name="journal"><space/>The American Journal of Pathology<space/></arg><arg name="volume"><space/>175<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>882–90<space/></arg><arg name="date"><space/>Aug 2009<space/></arg><arg name="pmid"><space/>19608864<space/></arg><arg name="pmc"><space/>2716982<space/></arg><arg name="doi"><space/>10.2353/ajpath.2009.080417<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S<space/></arg><arg name="title"><space/>Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study<space/></arg><arg name="journal"><space/>Diabetes Care<space/></arg><arg name="volume"><space/>33<space/></arg><arg name="issue"><space/>10<space/></arg><arg name="pages"><space/>2250–3<space/></arg><arg name="date"><space/>Oct 2010<space/></arg><arg name="pmid"><space/>20628086<space/></arg><arg name="pmc"><space/>2945168<space/></arg><arg name="doi"><space/>10.2337/dc10-0452<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Nabi MO, Mirabzadeh A, Feizzadeh G, Khorshid HR, Karimlou M, Yeganeh MZ, Asgharian AM, Najmabadi H, Ohadi M<space/></arg><arg name="title"><space/>Novel mutations in the calreticulin gene core promoter and coding sequence in schizoaffective disorder<space/></arg><arg name="journal"><space/>American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : The Official Publication of the International Society of Psychiatric Genetics<space/></arg><arg name="volume"><space/>153B<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>706–9<space/></arg><arg name="date"><space/>Mar 2010<space/></arg><arg name="pmid"><space/>19760677<space/></arg><arg name="doi"><space/>10.1002/ajmg.b.31036<space/></arg></template></listitem><listitem><template><target>cite journal</target><arg name="vauthors"><space/>Schardt JA, Eyholzer M, Timchenko NA, Mueller BU, Pabst T<space/></arg><arg name="title"><space/>Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia<space/></arg><arg name="journal"><space/>Journal of Cellular and Molecular Medicine<space/></arg><arg name="volume"><space/>14<space/></arg><arg name="issue"><space/>6B<space/></arg><arg name="pages"><space/>1509–19<space/></arg><arg name="date"><space/>Jun 2010<space/></arg><arg name="pmid"><space/>19659458<space/></arg><arg name="doi"><space/>10.1111/j.1582-4934.2009.00870.x<space/></arg></template></listitem></list><paragraph><template><target>refend</target></template></paragraph><heading level='2'>External links</heading><list type='bullet'><listitem><template><target>MeshName</target><arg>Calreticulin</arg></template></listitem></list><paragraph><template><target>Antiangiogenics</target></template><template><target>PDB Gallery</target><arg name="geneid">811</arg></template><template><target>Calcium-binding proteins</target></template><template><target>Lectins</target></template></paragraph><paragraph><link><target>Category:C-type lectins</target></link><link><target>Category:Immune system</target></link><link><target>Category:Proteins</target></link><link><target>Category:Cell signaling</target></link><link><target>Category:Signal transduction</target></link></paragraph></article>